Treatment
Medication clinical trials
We’re tracking 7,451 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT06493734Recruiting
SBRT after chemotherapy for inoperable bile duct cancer
This trial tests if a precise type of radiation (SBRT) can help people with inoperable bile duct cancer after they finish chemotherapy. It aims to control the tumor and improve outcomes.
Wilrijk, AntwerpAges 18 years+ - NCT06493890Recruiting
Validating a Dutch questionnaire for prosthesis users
This study aims to validate a Dutch version of a questionnaire that measures how well people feel their prosthetic leg works for them. The goal is to make sure the Dutch version is accurate and helpful for people with one leg amputation.
Groningen, Provincie GroningenAges 18 years+ - NCT06494072RecruitingPhase 4
Short vs standard antibiotics for kids hospitalized with pneumonia
This trial compares a shorter course of antibiotics to the usual longer course for children hospitalized with uncomplicated bacterial pneumonia. The goal is to see if fewer days of antibiotics work just as well, which could reduce side effects and make treatment easier.
Milwaukee, WisconsinAges 3 months–18 years - NCT06494124Recruiting
Brain stimulation for schizophrenia symptoms
This study compares two types of mild brain stimulation—tACS and tDCS—to see if they can help reduce symptoms of schizophrenia. It is for people who have had moderate to severe symptoms for at least two years and are on stable medications.
Bhubaneswar, OdishaAges 18–60 - NCT06497738Recruiting
Comparing two drug combos for elderly myeloma
This trial compares two different drug combinations (DRd and VRd-lite) for older adults (65+) who are newly diagnosed with multiple myeloma. The goal is to see which combination works better and is easier to tolerate.
Changzhou, JiangsuAges 65 years+ - NCT06498037RecruitingPhase 4
Better fentanyl dosing for cancer pain
This trial is testing a new way to give fentanyl under the skin for cancer-related pain. The goal is to find the right dose quickly and safely to make sure you get enough pain relief.
Rotterdam, South HollandAges 18–120 - NCT06498154RecruitingPhase 2
Skipping breast surgery for some patients after chemo
This trial tests whether women with certain aggressive breast cancers (HER2-positive without hormone receptors, or triple-negative) can safely skip breast surgery if chemotherapy makes their tumor completely disappear. The goal is to avoid surgery and its side effects when it may no longer be needed.
TianjinAges 18–70 - NCT06498752RecruitingPhase 2
MRD-guided consolidation therapy after radiation for esophageal cancer
This trial looks at whether a treatment guided by a blood test (MRD) after radiation can help prevent esophageal cancer from coming back. It tests a personalized approach to decide if more treatment is needed.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06498973RecruitingPhase 1
Maintenance therapy after stem cell transplant for CD123-positive AML/MDS
This trial tests a combination of two drugs, tagraxofusp and azacitidine, given as maintenance therapy after a stem cell transplant. The goal is to prevent the leukemia or MDS from coming back in patients whose cancer cells carry a specific marker called CD123.
Duarte, CaliforniaAges 18–75 - NCT06499467Recruiting
Comparing second blood pressure medicines for septic shock
This trial tests different combinations of blood pressure medicines given to patients on a breathing machine who have septic shock. The goal is to find the best dose of a second medicine when norepinephrine alone isn't enough.
Lucknow, Uttar PradeshAges 18–80 - NCT06499415RecruitingPhase 4
Combination cream vs standard cream for precancerous skin spots
This trial tests if adding calcipotriol to a standard chemotherapy cream (5-fluorouracil) works better than the standard cream alone for treating actinic keratosis (precancerous sun-damaged skin spots). You may qualify if you have at least four spots on your face, scalp, neck, chest, or arms.
Heerlen, LimburgAges 18 years+ - NCT06499974Recruiting
Preoperative Anemia Severity and Classification Before Surgery
This study looks at how different levels and types of anemia (low red blood cells) before planned surgery affect your recovery. If you have anemia and are having a moderate- to high-risk surgery (not brain or heart), you may be able to join to help doctors learn how to better prepare patients for surgery.
Wuhu, AnhuiAges 18 years+ - NCT06500169Recruiting
Golf exercise study for prostate cancer survivors
This study tests if golf can help men with prostate cancer feel better and stay healthy. It's for men who are on hormone therapy and want to try a gentle, fun exercise.
Los Angeles, CaliforniaAges 55–85 - NCT06500312Recruiting
Lung cancer imaging and genetics study
This study looks at how CT scans of lung cancer can be linked to the tumor's biology and genetics. It aims to understand lung cancer better by combining imaging with lab results.
Wuhan, HubeiAges 18 years+ - NCT06500403Recruiting
Non-invasive tools for liver injury after chemotherapy
This study tests non-invasive methods to diagnose a liver condition called PSVD in people who have received platinum chemotherapy. It may help find liver problems early without a biopsy.
Guangzhou, GuangdongAges 18–80 - NCT06500637RecruitingPhase 2
TB006 for autism in adults
This study tests an experimental medication called TB006 for adults with autism. It aims to see if it can help reduce symptoms. Participants must be 18–35, have moderate-to-severe autism, and have a caregiver who can join them.
Phoenix, ArizonaAges 18–35 - NCT06501599Recruiting
AI system for spotting COVID-19 lung changes on CT scans
This trial tests an artificial intelligence tool that helps doctors identify lung changes caused by viral pneumonia, like COVID-19, on CT scans. It may lead to faster and more accurate diagnosis for patients.
MoscowAges 18 years+ - NCT06501768RecruitingPhase 1/Phase 2
Genistein for heart failure inflammation
This trial tests a natural substance called genistein (found in soy) to reduce inflammation in people with heart failure. It may help your heart work better and feel better.
LjubljanaAges 40–80 - NCT06502145RecruitingPhase 1
Iadademstat with hypomethylating agent for MDS
This trial tests a new oral medication (iadademstat) combined with a standard therapy called a hypomethylating agent for people with higher-risk myelodysplastic syndromes (MDS) or related blood cancers. The goal is to see if the combination is safe and effective.
Milwaukee, WisconsinAges 18 years+ - NCT06502613Recruiting
Scoliosis and Sleep Cycle in Children
This study looks at how sleep timing (melatonin levels) might be linked to new cases of scoliosis in children. If you have scoliosis and are between 6 and 15, you may help researchers understand this connection.
Wenzhou, ZhejiangAges 6–15 - NCT06502925Recruiting
Study of emergency call handling quality
This study looks at how well emergency dispatch centers handle incoming calls. Researchers want to understand call quality when handled by professional dispatchers and exclude calls that are not real emergencies.
Besançon, Franche ComtéAges 18 years+ - NCT06503302Recruiting
Ultrasound effect on calcified shoulder tendinitis
This trial tests if using Doppler ultrasound to guide treatment can help people with long-term shoulder pain caused by calcified deposits. It may offer a more targeted way to relieve pain.
TaipeiAges 18–80 - NCT06503016RecruitingPhase 3
Phosphocreatine for medical emergency team patients
This study tests if a medicine called phosphocreatine helps people in the hospital who have a serious heart or lung emergency. It aims to see if the medicine can improve recovery and prevent further complications.
MilanAges 18 years+ - NCT06503094RecruitingPhase 1/Phase 2
CAR T cells targeting CD19 and CD20 for relapsed B-cell cancers
This trial tests a new type of CAR T-cell therapy that targets two markers (CD19 and CD20) on B-cell cancer cells. It is for people whose B-cell leukemia or lymphoma has come back or not responded to standard treatments.
Wuhan, HubeiAges 14–75
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,451 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.